Comments to: Ranibizumab for persistent diabetic macular edema after bevacizumab treatment

被引：2
|
作者：
Calugaru, Dan [1 ]
Calugaru, Mihai [1 ]
机构：
[1] Univ Med Cluj Napoca, Dept Ophthalmol, Cluj Napoca, Romania
来源：
EUROPEAN JOURNAL OF OPHTHALMOLOGY | 2017年 / 27卷 / 03期
关键词：
D O I：
10.5301/ejo.5000898
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：E104 / E105
页数：2
相关论文
共 50 条
  • [21] Letter to the Editor: Ranibizumab 0.3 mg for Persistent Diabetic Macular Edema After Recent, Frequent, and Chronic Bevacizumab: The ROTATE Trial
    Calugaru, Dan
    Calugaru, Mihai
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2018, 49 (03): : 160 - 160
  • [22] Short-Term Outcomes of Switching to Ranibizumab Therapy for Diabetic Macular Edema in Patients with Persistent Fluid After Bevacizumab Therapy
    Lee, Jae Hyung
    Lee, Won Ki
    Kim, Sung Eun
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2016, 32 (10) : 659 - 664
  • [23] The macular function and structure in patients with diabetic macular edema before and after ranibizumab treatment
    Barbara Nowacka
    Marta Kirkiewicz
    Katarzyna Mozolewska-Piotrowska
    Wojciech Lubiński
    Documenta Ophthalmologica, 2016, 132 : 111 - 122
  • [24] Frequency of Bevacizumab and Ranibizumab Injections for Diabetic Macular Edema in Medicare Beneficiaries
    Wu, Connie M.
    Wu, Annie M.
    Greenberg, Paul B.
    Yu, Fei
    Lum, Flora
    Coleman, Anne L.
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2018, 49 (04): : 241 - 244
  • [25] The macular function and structure in patients with diabetic macular edema before and after ranibizumab treatment
    Nowacka, Barbara
    Kirkiewicz, Marta
    Mozolewska-Piotrowska, Katarzyna
    Lubinski, Wojciech
    DOCUMENTA OPHTHALMOLOGICA, 2016, 132 (02) : 111 - 122
  • [26] Comparative Effectiveness Trial of Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
    Sun, Jennifer K.
    DIABETES, 2015, 64 : A76 - A77
  • [27] Intravitreal Fasudil Combined With Bevacizumab for Persistent Diabetic Macular Edema A Novel Treatment
    Ahmadieh, Hamid
    Nourinia, Ramin
    Hafezi-Moghadam, Ali
    JAMA OPHTHALMOLOGY, 2013, 131 (07) : 923 - 924
  • [28] Intravitreal Aflibercept Injection (IAI) for Persistent Diabetic Macular Edema (DME) after Treatment with Bevacizumab and/or Ranibizumab: 6-Month ROTATED Trial Results
    Marcus, Dennis M.
    Frazier, Heather
    Rex, Priscila
    Marcus, William
    Starnes, Davis
    Walia, Harveen
    Singh, Harinderjit
    Lalane, Robert
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [29] Ranibizumab in diabetic macular edema
    Krispel, Claudia
    Rodrigues, Murilo
    Xin, Xiaoban
    Sodhi, Akrit
    WORLD JOURNAL OF DIABETES, 2013, 4 (06) : 310 - 318
  • [30] Evaluation of the Response to Ranibizumab Therapy following Bevacizumab Treatment Failure in Eyes with Diabetic Macular Edema
    Hanhart, Joel
    Chowers, Itay
    CASE REPORTS IN OPHTHALMOLOGY, 2015, 6 (01): : 44 - 50
12345